This study aimed to determine the effect of type 2 diabetes mellitus (T2DM) on overall survival (OS) of patients with stage IIIB–IV non‐small cell lung cancer (NSCLC). Click to show full abstract
This study aimed to determine the effect of type 2 diabetes mellitus (T2DM) on overall survival (OS) of patients with stage IIIB–IV non‐small cell lung cancer (NSCLC).
               
Click one of the above tabs to view related content.